Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BODD ApS
APS
Active
CVR 39130009
Kåstrupvej 84
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2017
4 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 1M
-18% vs 2023
EBITDA margin
42.5%
+258% vs 2023
Equity ratio
14.0%
Financial strength
Net profit 2024
DKK 197K
+15% vs 2023
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK 1M
-18%
EBITDA
DKK 440K
+258%
Net profit
DKK 197K
+15%
Total assets
DKK 3,3M
+451%
Equity
DKK 464K
+19%
Employees
4
—
Company information
Legal name
BODD ApS
CVR number
39130009
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
29. november 2017
Share capital
DKK 40.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Company purpose
Selskabets formål er at drive konsulentvirksomhed indenfor naturvidenskab, ejendomsudvikling og anden hermed beslægtet virksomhed.
Contact
Address
Kåstrupvej 84
Phone
+4551594567
Email
wdb.pharma.consulting@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Kalundborg
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
1M
2023
1M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
50
135
499
1.264
1.036
Staff expenses
-0
-0
-0
-1.141
-596
EBITDA
50
135
499
123
440
Depreciation & amort.
-12
-12
-12
-12
-51
EBIT
38
123
487
111
389
Net financials
-0
-1
-1
109
-136
Profit before tax
38
122
486
220
253
Tax
-0
9
107
49
57
Net profit
38
113
379
172
197
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
184
336
434
601
3.314
Equity
-82
71
335
389
464
Long-term debt
0
0
0
0
0
Short-term debt
266
265
99
212
2.850
Total debt
266
265
99
212
2.850
Financial ratios
5-year trend
EBITDA margin
42.5%
This company
15.8%
Market median
+169% vs market
2020
2024
Equity ratio
14.0%
This company
38.2%
Market median
-63% vs market
2020
2024
Return on equity
42.4%
This company
18.4%
Market median
+130% vs market
2020
2024
Net profit margin
19.0%
This company
8.1%
Market median
+135% vs market
2020
2024
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
2020
2024
Debt / equity
6.14×
This company
0.62×
Market median
-890% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
William Brown
Individual
100%
100%
2017
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
BODD ApS
(this company)
Synuca Therapeutics ApS
Board network connections
Board members of BODD ApS also hold positions in
0
other companies.
Person
Role here
Other companies